MYELOSTAT 500MG contains Hydroxyurea which belongs to the group of medicines called antineoplastic agents. It is indicated for the treatment of resistant chronic myelocytic leukemia (blood cell cancer), ovarian cancer, and skin cancer (melanoma).
 

Additional Information:

• Production Capacity: As per requirement
• Delivery Time: 5 to 7 working days
• Packaging Details: Box packing / Quality bubbled envelope.